First or Second Line HER2-negative Breast Cancer
1 clinical trials · Condition
◉ Watch First or Second Line HER2-negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients (NCT01129336) | Novartis Pharmaceuticals | 2010-06-01 |
Track First or Second Line HER2-negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.